• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Champions Oncology, Inc. - Common Stock (NQ:CSBR)

    6.415 -0.055 (-0.85%)
    Streaming Delayed Price Updated: 10:20 AM EDT, Oct 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,253
    Open 6.500
    Bid (Size) 6.390 (1)
    Ask (Size) 6.450 (36)
    Prev. Close 6.470
    Today's Range 6.332 - 6.500
    52wk Range 3.750 - 11.99
    Shares Outstanding 13,415,066
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss
    Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
    Via Chartmill

    Performance

    YTD
    -21.8%
    -21.8%
    1 Month
    -9.1%
    -9.1%
    3 Month
    -11.0%
    -11.0%
    6 Month
    -25.5%
    -25.5%
    1 Year
    +31.7%
    +31.7%

    More News

    Read More
    Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    Earnings Scheduled For September 15, 2025
    Via Benzinga
    Insights Ahead: Champions Oncology's Quarterly Earnings
    Via Benzinga
    Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
    Via ACCESS Newswire
    Champions Oncology Reports Record Annual Revenue of $57 Million
    Via ACCESS Newswire
    Earnings Scheduled For July 23, 2025
    Via Benzinga
    4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
    Via Benzinga
    Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
    Via ACCESS Newswire
    Champions Oncology Announces Appointment of New CEO
    Via ACCESS Newswire
    Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
    Via ACCESS Newswire
    Recap: Champions Oncology Q2 Earnings
    Via Benzinga
    A Peek at Champions Oncology's Future Earnings
    Via Benzinga
    Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
    Via ACCESS Newswire
    Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
    Via ACCESS Newswire
    Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
    Via ACCESS Newswire
    Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
    Via ACCESS Newswire
    Earnings Scheduled For March 11, 2025
    Via Benzinga
    Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
    Via ACCESS Newswire
    Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
    Via ACCESSWIRE
    Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
    Via ACCESSWIRE
    Earnings Scheduled For December 11, 2024
    Via Benzinga

    Frequently Asked Questions

    Is Champions Oncology, Inc. - Common Stock publicly traded?
    Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
    What exchange does Champions Oncology, Inc. - Common Stock trade on?
    Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
    The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
    What is the current price of Champions Oncology, Inc. - Common Stock?
    The current price of Champions Oncology, Inc. - Common Stock is 6.415
    When was Champions Oncology, Inc. - Common Stock last traded?
    The last trade of Champions Oncology, Inc. - Common Stock was at 10/01/25 10:20 AM ET
    What is the market capitalization of Champions Oncology, Inc. - Common Stock?
    The market capitalization of Champions Oncology, Inc. - Common Stock is 86.06M
    How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
    Champions Oncology, Inc. - Common Stock has 86M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.